April 16, 2025 - 17:47

The rapid progress of artificial intelligence (AI) in China has raised alarms among US officials and lawmakers, leading to discussions about potential regulations and investigations aimed at curbing Beijing's advancements in the sector. The growing capabilities of Chinese tech companies, particularly in AI, have sparked fears that they could outpace American innovations and pose national security risks.
In response, the Trump administration is considering measures that could include increased scrutiny of companies like Nvidia and DeepSeek, which are seen as pivotal players in the AI landscape. These actions may involve stricter export controls on technology that could be utilized for military applications or other sensitive areas.
Lawmakers are also exploring legislative avenues to address the competitive threat posed by China's burgeoning AI sector. As the race for AI supremacy intensifies, the US is grappling with the implications of China's technological rise, emphasizing the need for a strategic approach to maintain its leadership in the global tech arena.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...